regenerative allogeneic induced pluripotent stem cell therapy (MyoPax)

N/A

Report date: 2025/06/11 10:22:34

Base Information

Drug Nameregenerative allogeneic induced pluripotent stem cell therapy (MyoPax)
Drug Alias NameSatuni
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMuscular Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMyoPax
China Registration ClassN/A

Develop Information

Active CompaniesMyoPax
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A